WOLVERINE TRADING, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 67 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$378,031
+2100072.2%
174,208
+1240.1%
0.00%
Q4 2022$18
-99.9%
13,000
+8.3%
0.00%
Q2 2022$13,000
-53.6%
12,000
-63.3%
0.00%
Q4 2021$28,000
-83.4%
32,700
-73.4%
0.00%
Q3 2021$169,000
-46.7%
123,068
-25.8%
0.00%
Q2 2021$317,000
+3.6%
165,806
+144.2%
0.00%
Q1 2021$306,000
+705.3%
67,898
+524.2%
0.00%
Q4 2020$38,000
-17.4%
10,878
-7.8%
0.00%
Q3 2020$46,000
-16.4%
11,800
-49.4%
0.00%
Q1 2020$55,00023,3000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Orin Green Financial, LLC 80,000$132,8000.07%
GSA CAPITAL PARTNERS LLP 496,781$8250.07%
DENALI ADVISORS LLC 110,200$182,9320.06%
XTX Topco Ltd 83,973$139,3950.02%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$43,1170.02%
State of Wyoming 41,268$68,5050.02%
HARBOUR INVESTMENT MANAGEMENT LLC 10,100$16,7660.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 158,790$263,5910.01%
Truvestments Capital LLC 3,880$6,4410.00%
Renaissance Technologies 621,100$1,0310.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders